BiochemProbe — Life Science Research Reagents

AZD-4635 free base · Synonyms: Imaradenant | HTL1071

Imaradenant is an oral A2AR antagonist.

For research use only. Not for human or veterinary use.

Research area Cancer
Purity >98% Stock Inquire

AZD-4635 structure

CAS No.: 1321514-06-0

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
500 mg USD 480.00 BP-01868-500mg In stock Get quote
1 g USD 780.00 BP-01868-1g In stock Get quote
5 g Inquire BP-01868-5g In stock Inquire
10 g Inquire BP-01868-10g Inquire Inquire

Need another size or custom synthesis? Request a quote.

Description

Imaradenant (AZD4635, HTL1071) is an oral A2AR antagonist that binds to human A2AR with a Ki of 1.7 nM and with > 30-fold selectivity over other adenosine receptors.

Biological activity

In Vitro In the presence of 0.1, 1 and 10 μM adenosine, the IC50s of AZD4635 for inhibition of cAMP production are 0.79, 10.0 and 142.9 nM, respectively.

Identifiers

SMILES
CC1=CC(=CC(Cl)=N1)C1=C(N=C(N)N=N1)C1=CC=C(F)C=C1
InChIKey
NCWQLHHDGDXIJN-UHFFFAOYSA-N

Specifications

MW (average)
315.7330
Formula
C15H11ClFN5
CAS No.
1321514-06-0
Physical state
Solid
Color
Off-white to yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

References

[1]. Jazayeri A, Andrews SP, Marshall FH. Structurally Enabled Discovery of Adenosine A(2A) Receptor Antagonists. Chem Rev. 2017 Jan 11;117(1):21-37. doi:10.1021/acs.chemrev.6b00119. Epub 2016 Jun 22. Review. PubMed PMID: 27333206.
[2]. Alexandra Borodovsky, et al. Preclinical pharmacodynamics and antitumor activity of AZD4635, a novel adenosine 2A receptor inhibitor that reverses adenosine mediated T cell suppression. AACR Cancer Res. 2017, 77(13 Suppl):Abstract nr 5580.

Same research area

Search Cancer